Drug Target Review·3 min read·hard
New BET therapies could help beat resistance in solid cancers
D
Drug Target Review
✦AI Summary
New research into BET protein inhibitors suggests that next-generation therapies may overcome previous clinical limitations such as drug resistance and side effects in solid tumor treatments. By targeting proteins like BRD4, scientists aim to improve the efficacy of cancer treatments that previously struggled in clinical trials.
New research suggests that the next generation of therapies targeting BET proteins could overcome the limitations of earlier drugs and improve treatment options for patients with a range of solid tumours .
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in